Myriad Genetics Ratios (2009-2026) | MYGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	74.66%	100.00%	179.60%	70.89%	72.28%	67.77%	33.24%	67.33%	68.50%	69.98%	41.71%	68.05%	69.55%	70.23%	71.65%	68.50%	71.23%	69.91%	69.97%	68.66%
EBT Margin (Quarter)	-2.01%	23.79%	-27.05%	-16.01%	-9.98%	-28.26%	-29.30%	-29.03%	-63.27%	-31.89%	-16.43%	-12.81%	-17.59%	-9.94%	-18.57%	-15.01%	-155.14%	-12.74%	-4.24%	-17.02%
EBIT Margin (Quarter)	-10.98%	-47.76%	-26.80%	-15.52%	-9.93%	-28.77%	-29.36%	-28.81%	-61.96%	-31.32%	-15.97%	-13.80%	-17.26%	-9.38%	-18.52%	-14.80%	-154.48%	-11.33%	-2.72%	-15.32%
EBITDA Margin (Quarter)	-10.98%	-47.76%	-26.80%	-15.52%	-9.93%	-28.77%	-29.36%	-28.81%	-61.96%	-31.32%	-15.97%	-13.80%	-17.26%	-9.38%	-18.52%	-14.80%	-154.48%	-11.33%	-2.72%	-15.32%
Operating Margin (Quarter)	-10.98%	-47.76%	-26.80%	-15.52%	-9.93%	-28.77%	-29.36%	-28.81%	-61.96%	-31.32%	-15.97%	-13.80%	-17.26%	-9.38%	-18.52%	-14.80%	-154.48%	-11.33%	-2.72%	-15.32%
Net Margin (Quarter)	-2.48%	14.70%	-4.73%	-12.43%	-7.86%	-22.44%	-23.79%	-30.19%	-63.27%	-31.94%	-15.87%	-12.86%	-17.35%	-10.36%	-20.18%	-0.05%	-155.09%	-13.32%	-3.77%	-17.02%
FCF Margin (Quarter)	-4.70%	-25.28%	-8.02%	-32.02%	-31.46%	6.52%	-29.58%	-31.29%	-10.74%	7.09%	-56.61%	-12.51%	-1.23%	-1.31%	1.42%	-11.03%	-7.70%	8.90%	2.81%	-10.53%
Efficiency
Inventory Average (Quarter)	21.15M	18.15M	16.95M	15.45M	15.50M	17.50M	19.85M	20.95M	22.15M	23.80M	23.55M	23.30M	25.35M	26.15M	26.85M	27.90M	28.50M	30.15M	31.10M	29.25M
Assets Average (Quarter)	1,348.60M	1,348.10M	1,328.30M	1,288.05M	1,232.80M	1,211.10M	1,205.35M	1,184.00M	1,178.25M	1,168.15M	1,147.80M	1,128.50M	1,097.80M	1,083.20M	1,054.45M	1,016.85M	841.70M	702.70M	717.35M	690.15M
Equity Average (Quarter)	888.80M	935.45M	968.15M	958.95M	948.75M	932.00M	901.20M	860.50M	785.20M	709.30M	733.30M	771.60M	750.25M	736.10M	716.40M	703.00M	546.50M	380.45M	370.40M	352.70M
Invested Capital (Quarter)	1,006.50M	968.50M	967.80M	950.10M	947.40M	916.60M	885.80M	835.20M	775.20M	723.40M	821.70M	800.00M	780.50M	771.70M	740.70M	764.20M	447.50M	492.30M	487.90M	457.70M
Asset Utilization Ratio (Quarter)	0.60	0.62	0.52	0.53	0.55	0.55	0.56	0.59	0.59	0.63	0.66	0.69	0.73	0.76	0.79	0.82	0.99	1.17	1.15	1.20
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-10.40	-72.64	-86.20	-28.44	-29.67	-56.25	-58.00	-104.40	-227.40	-60.10	-34.89	-55.80	-45.63	-25.00	-55.71	-36.25	-219.47	-6.13	-1.30	-7.49
Debt to Equity (Quarter)	0.12								0.05	0.06	0.05	0.05	0.05	0.05	0.06	0.08	0.15	0.32	0.33	0.36
Debt Ratio (Quarter)	0.08								0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.06	0.09	0.16	0.17	0.18
Equity Ratio (Quarter)	0.66	0.72	0.73	0.76	0.78	0.76	0.74	0.71	0.62	0.59	0.68	0.68	0.68	0.68	0.68	0.70	0.57	0.51	0.52	0.50
Times Interest Earned (Quarter)	-10.40	-72.64	-86.20	-28.44	-29.67	-56.25	-58.00	-104.40	-227.40	-60.10	-34.89	-55.80	-45.63	-25.00	-55.71	-36.25	-219.47	-6.13	-1.30	-7.49
Valuation
Enterprise Value (Quarter)	-164.50M	-366.20M	-338.80M	-267.40M	-204.10M	-191.20M	-114.90M	-78.70M	-121.60M	-86.30M	-140.90M	-104.30M	-97.30M	-99.90M	-102.40M	-91.80M	-74.40M	-145.40M	-149.60M	-124.40M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.02%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-18.09%	-20.54%	-16.95%	-15.10%	-14.95%	-12.15%	-13.16%	-16.07%	-27.49%	-29.01%	-25.95%	-23.73%	-16.43%	-12.47%	-13.86%	-14.38%	-65.00%	-75.81%	-66.35%	-69.45%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Myriad Genetics Ratios (2009-2026) | MYGN

Create an account

Sign In

Reset Password